Phase II clinical trial of recombinant human granulocyte colony-stimulating factor(fhG-CSF)(KRN8601) in advanced cancer patients with myelosuppression after chemotherapy / 대한암학회지
Journal of the Korean Cancer Association
;
: 725-735, 1993.
Article
in Korean
| WPRIM
| ID: wpr-31786
ABSTRACT
No abstract available.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Drug Therapy
/
Granulocytes
Limits:
Humans
Language:
Korean
Journal:
Journal of the Korean Cancer Association
Year:
1993
Type:
Article
Similar
MEDLINE
...
LILACS
LIS